OptiNose, Inc. (OPTN)

USD 9.4

(0.11%)

Total Debt Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual total debt in 2023 was 131.74 Million USD , up 0.44% from previous year.
  • OptiNose, Inc.'s latest quarterly total debt in 2024 Q2 was 126.15 Million USD , down -3.97% from previous quarter.
  • OptiNose, Inc. reported annual total debt of 131.17 Million USD in 2022, up 0.36% from previous year.
  • OptiNose, Inc. reported annual total debt of 130.7 Million USD in 2021, up 4.39% from previous year.
  • OptiNose, Inc. reported quarterly total debt of 131.37 Million USD for 2024 Q1, down -0.28% from previous quarter.
  • OptiNose, Inc. reported quarterly total debt of 131.74 Million USD for 2023 Q4, up 0.61% from previous quarter.

Annual Total Debt Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Total Debt of OptiNose, Inc. (2023 - 2015)

Year Total Debt Total Debt Growth
2023 131.74 Million USD 0.44%
2022 131.17 Million USD 0.36%
2021 130.7 Million USD 4.39%
2020 125.2 Million USD 67.99%
2019 74.53 Million USD 2.8%
2018 72.5 Million USD 0.89%
2017 71.86 Million USD 371.05%
2016 15.25 Million USD 5.36%
2015 14.48 Million USD 0.0%

Peer Total Debt Comparison of OptiNose, Inc.

Name Total Debt Total Debt Difference
Esperion Therapeutics, Inc. 540.94 Million USD 75.645%
Theratechnologies Inc. 58.96 Million USD -123.425%
Safety Shot Inc 1.54 Million USD -8405.566%
Cosmos Health Inc. 12.42 Million USD -960.444%
Cronos Group Inc. 2.53 Million USD -5087.095%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 81.587%
Kala Pharmaceuticals, Inc. 36.32 Million USD -262.715%
Organogenesis Holdings Inc. 119.35 Million USD -10.388%
Universe Pharmaceuticals INC 5.48 Million USD -2303.102%
ProPhase Labs, Inc. 21.38 Million USD -516.225%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -21569.243%
Dynavax Technologies Corporation 256.91 Million USD 48.719%
Radius Health, Inc. 365.31 Million USD 63.935%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -4876.44%
Alvotech 1.07 Billion USD 87.75%
Sunshine Biopharma, Inc. 657.7 Thousand USD -19931.625%
Alpha Teknova, Inc. 30.45 Million USD -332.56%
Intra-Cellular Therapies, Inc. 16.93 Million USD -677.831%
SCYNEXIS, Inc. 15.08 Million USD -773.667%
Harrow Health, Inc. 190.5 Million USD 30.841%
Biofrontera Inc. 5.39 Million USD -2340.248%
DURECT Corporation 20.74 Million USD -535.057%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -217.261%
ANI Pharmaceuticals, Inc. 315.32 Million USD 58.218%
RedHill Biopharma Ltd. 1.17 Million USD -11131.741%
Aquestive Therapeutics, Inc. 98.82 Million USD -33.32%
Cumberland Pharmaceuticals Inc. 18.42 Million USD -614.92%
SIGA Technologies, Inc. 1.46 Million USD -8899.193%
Lifecore Biomedical, Inc. 130.36 Million USD -1.066%
Shineco, Inc. 29.65 Million USD -344.251%
Phibro Animal Health Corporation 525.45 Million USD 74.927%
Procaps Group S.A. 285.93 Million USD 53.923%
TherapeuticsMD, Inc. 8 Million USD -1545.834%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -220190.267%
Viatris Inc. 18.12 Billion USD 99.273%
Sunshine Biopharma, Inc. 657.7 Thousand USD -19931.625%
Rockwell Medical, Inc. 13.43 Million USD -880.348%
Incannex Healthcare Limited 373 Thousand USD -35221.448%
Aytu BioPharma, Inc. 15.12 Million USD -770.837%
Tilray Brands, Inc. 387.31 Million USD 65.984%
Collegium Pharmaceutical, Inc. 674.28 Million USD 80.461%
PetIQ, Inc. 468.3 Million USD 71.867%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 428.4 Million USD 69.246%
Journey Medical Corporation 17.73 Million USD -643.085%
Alimera Sciences, Inc. 67.39 Million USD -95.476%
Petros Pharmaceuticals, Inc. 8.27 Million USD -1491.827%
Assertio Holdings, Inc. 40.91 Million USD -222.03%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -12012.69%
Embecta Corp. 1.63 Billion USD 91.959%
Cyclo Therapeutics, Inc. 1.03 Million USD -12652.598%
Procaps Group, S.A. 285.93 Million USD 53.923%
PainReform Ltd. 86 Thousand USD -153096.512%
Avadel Pharmaceuticals plc 35.38 Million USD -272.341%
Hempacco Co., Inc. 13.72 Million USD -859.954%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 77.519%
Alvotech 1.07 Billion USD 87.75%
Lantheus Holdings, Inc. 616.94 Million USD 78.645%
Kamada Ltd. 8.74 Million USD -1405.877%
Indivior PLC 281.6 Million USD 53.214%
Currenc Group, Inc. 31.94 Million USD -312.442%
Evoke Pharma, Inc. 5 Million USD -2534.98%
Flora Growth Corp. 3.67 Million USD -3487.936%
Cyclo Therapeutics, Inc. 1.03 Million USD -12652.598%
Evolus, Inc. 126.54 Million USD -4.112%
HUTCHMED (China) Limited 86.13 Million USD -52.964%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 78.874%
Akanda Corp. 3.99 Million USD -3194.721%